Cytotoxic and stimulatory effects of antilymphocyte globulin (ALG) on hematopoiesis
- 1 May 1990
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 60 (5) , 297-300
- https://doi.org/10.1007/bf01736232
Abstract
Summary Four different preparations of antilymphocyte/antithymocyte globulin were tested in vitro for their toxicity to lymphocytes and to hematopoietic precursor cells, depending on concentration and time. Complete lymphocytotoxicity was observed at concentrations from 6.3 to 25µg/ml, and suppression of colony formation by hematopoietic precursors was seen at concentrations from 12.5 to 250µg/ml. Prolonged incubation time did not increase lymphocytotoxicity but augmented precursor cell damage. Lymphocytotoxicity was comparable among the four preparations tested whereas precursor cell toxicity varied widely. Antilymphocyte globulin is mitogenic and stimulates the release of hematopoietic growth factor activity by peripheral blood cells. Absorption of ALG with human T-cells eliminated precursor cell toxicity and mitogenicity but not the capacity to release hematopoietic growth factors. These results show that dose/time schedules for ALG administration may be relevant and ALG acts by virtue of inhibitory and stimulatory antibody effects.Keywords
This publication has 12 references indexed in Scilit:
- ANTI-LYMPHOCYTE GLOBULIN STIMULATES NORMAL HUMAN T-CELLS TO PROLIFERATE AND TO RELEASE LYMPHOKINES INVITRO - A STUDY AT THE CLONAL LEVEL1988
- Anti-lymphocyte globulin stimulates normal human T cells to proliferate and to release lymphokines in vitro. A study at the clonal levelBlood, 1988
- Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor.Journal of Clinical Investigation, 1988
- Immunostimulatory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effectBritish Journal of Haematology, 1988
- BIOLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF ATG AND ALG1986
- TREATMENT OF SEVERE APLASTIC-ANEMIA1986
- A RANDOMIZED TRIAL OF ANTIHUMAN THYMOCYTE GLOBULIN VERSUS MURINE MONOCLONAL ANTIHUMAN T-CELL ANTIBODIES AS IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC-ANEMIA1985
- LYMPHOKINE ABNORMALITIES IN APLASTIC-ANEMIA - IMPLICATIONS FOR THE MECHANISM OF ACTION OF ANTITHYMOCYTE GLOBULIN1985
- Antithymocyte and antilymphocyte globulins: clinical trials and mechanism of action.1984
- EFFECT OF CRUDE AND DIFFERENTLY ABSORBED ANTI-HUMAN T-CELL GLOBULIN ON GRANULOCYTIC AND ERYTHROPOIETIC COLONY FORMATION1978